Systemic administration of ivabradine, a hyperpolarization-activated cyclic nucleotide-gated channel inhibitor, blocks spontaneous absence seizures

Objective Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are known to be involved in the generation of absence seizures (ASs), and there is evidence that cortical and thalamic HCN channel dysfunctions may have a proabsence role. Many HCN channel blockers are available, but their...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Iacone Yasmine
Morais Tatiana P.
David Francois
Delicata Francis
Sandle Joanna
Raffai Tímea
Parri Harri Rheinallt
Weisser Johan Juhl
Bundgaard Christoffer
Klewe Ib Vestergaard
Tamás Gábor
Thomsen Morten Skøtt
Crunelli Vincenzo
Lőrincz László Magor
Dokumentumtípus: Cikk
Megjelent: 2021
Sorozat:EPILEPSIA 62 No. 7
Tárgyszavak:
doi:10.1111/epi.16926

mtmt:32037613
Online Access:http://publicatio.bibl.u-szeged.hu/23324
LEADER 03422nab a2200385 i 4500
001 publ23324
005 20220128114853.0
008 220128s2021 hu o 0|| Angol d
022 |a 0013-9580 
024 7 |a 10.1111/epi.16926  |2 doi 
024 7 |a 32037613  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Angol 
100 1 |a Iacone Yasmine 
245 1 0 |a Systemic administration of ivabradine, a hyperpolarization-activated cyclic nucleotide-gated channel inhibitor, blocks spontaneous absence seizures  |h [elektronikus dokumentum] /  |c  Iacone Yasmine 
260 |c 2021 
300 |a 1729-1743 
490 0 |a EPILEPSIA  |v 62 No. 7 
520 3 |a Objective Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are known to be involved in the generation of absence seizures (ASs), and there is evidence that cortical and thalamic HCN channel dysfunctions may have a proabsence role. Many HCN channel blockers are available, but their role in ASs has been investigated only by localized brain injection or in in vitro model systems due to their limited brain availability. Here, we investigated the effect on ASs of orally administered ivabradine (an HCN channel blocker approved for the treatment of heart failure in humans) following injection of the P-glycoprotein inhibitor elacridar, which is known to increase penetration into the brain of drug substrates for this efflux transporter. The action of ivabradine was also tested following in vivo microinjection into the cortical initiation network (CIN) of the somatosensory cortex and in the thalamic ventrobasal nucleus (VB) as well as on cortical and thalamocortical neurons in brain slices. Methods We used electroencephalographic recordings in freely moving Genetic Absence Epilepsy Rats From Strasbourg (GAERSs) to assess the action of oral administration of ivabradine, with and without elacridar, on ASs. Ivabradine was also microinjected into the CIN and VB of GAERSs in vivo and applied to Wistar CIN and GAERS VB slices while recording patch-clamped cortical Layer 5/6 and thalamocortical neurons, respectively. Results Oral administration of ivabradine markedly and dose-dependently reduced ASs. Ivabradine injection into CIN abolished ASs and elicited small-amplitude 4-7-Hz waves (without spikes), whereas in the VB it was less potent. Moreover, ivabradine applied to GAERS VB and Wistar CIN slices selectively decreased HCN channel-dependent properties of cortical Layer 5/6 pyramidal and thalamocortical neurons, respectively. Significance These results provide the first demonstration of the antiabsence action of a systemically administered HCN channel blocker, indicating the potential of this class of drugs as a novel therapeutic avenue for ASs. 
650 4 |a Biológiai tudományok 
650 4 |a Klinikai orvostan 
700 0 1 |a Morais Tatiana P.  |e aut 
700 0 1 |a David Francois  |e aut 
700 0 1 |a Delicata Francis  |e aut 
700 0 1 |a Sandle Joanna  |e aut 
700 0 1 |a Raffai Tímea  |e aut 
700 0 1 |a Parri Harri Rheinallt  |e aut 
700 0 1 |a Weisser Johan Juhl  |e aut 
700 0 1 |a Bundgaard Christoffer  |e aut 
700 0 1 |a Klewe Ib Vestergaard  |e aut 
700 0 1 |a Tamás Gábor  |e aut 
700 0 1 |a Thomsen Morten Skøtt  |e aut 
700 0 1 |a Crunelli Vincenzo  |e aut 
700 0 1 |a Lőrincz László Magor  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/23324/1/LorinczM_Epilepsia_2021.pdf  |z Dokumentum-elérés